메뉴 건너뛰기




Volumn 59, Issue 3, 2012, Pages 550-551

Heart smart insulin-like growth factor 1

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

EID: 84857595431     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.188441     Document Type: Note
Times cited : (4)

References (10)
  • 1
    • 59449110658 scopus 로고    scopus 로고
    • Western diet impairs metabolic remodelling and contractile efficiency in cardiac hypertrophy
    • Akki A, Seymour AM. Western diet impairs metabolic remodelling and contractile efficiency in cardiac hypertrophy. Cardiovasc Res. 2009;81: 610-617.
    • (2009) Cardiovasc Res. , vol.81 , pp. 610-617
    • Akki, A.1    Seymour, A.M.2
  • 5
    • 84863115697 scopus 로고    scopus 로고
    • Insulin- like growth factor 1 alleviates high-fat diet-induced myocardial contractile dysfunction: Role of insulin signaling and mitochondrial function
    • Zhang Y, Yuan M, Bradley KM, Dong F, Anversa P, Ren J. Insulin- like growth factor 1 alleviates high-fat diet-induced myocardial contractile dysfunction role of insulin signaling and mitochondrial function Hypertension. 2012:59;680- 693.
    • (2012) Hypertension , vol.59 , pp. 680-693
    • Zhang, Y.1    Yuan, M.2    Bradley, K.M.3    Dong, F.4    Anversa, P.5    Ren, J.6
  • 7
    • 78650121847 scopus 로고    scopus 로고
    • Molecular distinction between physiological and pathological cardiac hypertrophy: Experimental findings and therapeutic strategies
    • Bernardo BC, Weeks KL, Pretorius L, McMullen JR. Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies. Pharmacol Ther. 2010; 128:191-227.
    • (2010) Pharmacol Ther. , vol.128 , pp. 191-227
    • Bernardo, B.C.1    Weeks, K.L.2    Pretorius, L.3    McMullen, J.R.4
  • 9
    • 77953202134 scopus 로고    scopus 로고
    • Cardiac-specific IGF-1 receptor transgenic expression protects against cardiac fibrosis and diastolic dysfunction in a mouse model of diabetic cardiomyopathy
    • Huynh K, McMullen JR, Julius TL, Tan JW, Love JE, Cemerlang N, Kiriazis H, Du XJ, Ritchie RH. Cardiac-specific IGF-1 receptor transgenic expression protects against cardiac fibrosis and diastolic dysfunction in a mouse model of diabetic cardiomyopathy. Diabetes. 2010; 59:1512-1520.
    • (2010) Diabetes. , vol.59 , pp. 1512-1520
    • Huynh, K.1    McMullen, J.R.2    Julius, T.L.3    Tan, J.W.4    Love, J.E.5    Cemerlang, N.6    Kiriazis, H.7    Du, X.J.8    Ritchie, R.H.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.